|
× |
 |
Suicidality, Depression, and the FDA: Health Inequities and the Ethical Conduct of Research PDF |
$40.00 |
|
$40.00 |
|
× |
|
Patient Health Questionnaire Depression Scale as a Suicide Screening Instrument in Depressed Primary Care Patients: A Cross-Sectional Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Separation Anxiety and Measures of Suicide Risk Among Patients With Mood and Anxiety Disorders PDF |
$40.00 |
|
$40.00 |
|
× |
|
Wellness Intervention for Patients With Serious and Persistent Mental Illness PDF |
$40.00 |
|
$40.00 |
|
× |
|
Borderline Personality Symptomatology, Experience of Multiple Types of Trauma, and Health Care Utilization Among Women in a Primary Care Setting PDF |
$40.00 |
|
$40.00 |
|
× |
|
Quetiapine Addition to Serotonin Reuptake Inhibitor Treatment in Patients With Treatment-Refractory Obsessive-Compulsive Disorder: An Open-Label Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Cocaine as a Risk Factor for Neuroleptic-Induced Acute Dystonia PDF |
$40.00 |
|
$40.00 |
|
× |
|
Long-Term Olanzapine Therapy in the Treatment of Bipolar I Disorder: An Open-Label Continuation Phase Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Personality and the Long-Term Outcome of First-Episode Depression: A Prospective 5-Year Follow-Up Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
The ɑ1-Adrenergic Antagonist Prazosin Ameliorates Combat Trauma Nightmares in Veterans With Posttraumatic Stress Disorder: A Report of 4 Cases PDF |
$40.00 |
|
$40.00 |
|
× |
|
Venlafaxine in Treatment-Resistant Obsessive-Compulsive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Efficacy, Safety, and Tolerability of Venlafaxine Extended Release and Buspirone in Outpatients With Generalized Anxiety Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
History of Concussion and Risk of Severe Maternal Mental Illness: A Population-Based Cohort Study PDF |
$40.00 |
|
$40.00 |
|
|
